{"drugs":["Isosulfan Blue","Lymphazurin"],"mono":{"0":{"id":"307240-s-0","title":"Generic Names","mono":"Isosulfan Blue"},"1":{"id":"307240-s-1","title":"Dosing and Indications","sub":{"0":{"id":"307240-s-1-4","title":"Adult Dosing","mono":"<ul><li>maximum recommended dose is 3 mL of the 1% solution (30 mg) per study<\/li><li><b>Lymphangiogram:<\/b> 0.5 mL of the 1% solution SUBQ into 3 interdigital spaces of each extremity per study; maximum of 3 mL (30 mg)<\/li><\/ul>"},"1":{"id":"307240-s-1-5","title":"Pediatric Dosing","mono":"safety and effectiveness in children have not been established "},"3":{"id":"307240-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Lymphangiogram<br\/>"}}},"3":{"id":"307240-s-3","title":"Contraindications\/Warnings","sub":[{"id":"307240-s-3-9","title":"Contraindications","mono":"known hypersensitivity to triphenylmethane or related compounds <br\/>"},{"id":"307240-s-3-10","title":"Precautions","mono":"<ul><li>bronchial asthma; serious hypersensitivity reactions more likely<\/li><li>interference with arterial blood gas measurement of methemoglobin; falsely high readings<\/li><li>interference with measurement of oxygen saturation level by peripheral blood pulse oximetry; falsely low readings; persists up to 4 hours after administration<\/li><li>serious hypersensitivity reactions, including life-threatening respiratory distress, shock, and angioedema, have occurred; monitoring recommended<\/li><\/ul>"},{"id":"307240-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"307240-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"307240-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Immunologic:<\/b>Hypersensitivity reaction (2%)<br\/><b>Serious<\/b><br\/><b>Immunologic:<\/b>Anaphylaxis<br\/>"},"6":{"id":"307240-s-6","title":"Drug Name Info","sub":{"0":{"id":"307240-s-6-17","title":"US Trade Names","mono":"Lymphazurin<br\/>"},"2":{"id":"307240-s-6-19","title":"Class","mono":"Diagnostic Agent, Lymphatic Visualization<br\/>"},"3":{"id":"307240-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"307240-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"8":{"id":"307240-s-8","title":"Pharmacokinetics","sub":{"1":{"id":"307240-s-8-24","title":"Distribution","mono":"Protein binding: yes <br\/>"},"3":{"id":"307240-s-8-26","title":"Excretion","mono":"Renal: up to 10% unchanged (24 hours) <br\/>"}}},"9":{"id":"307240-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/><ul><li>for subcutaneous administration<\/li><li>incompatible with local anesthetics; administer in a separate syringe<\/li><\/ul><\/li><li><b>Subcutaneous<\/b><br\/>inject SUBQ into interdigital spaces of each extremity per study<br\/><\/li><\/ul>"},"10":{"id":"307240-s-10","title":"Monitoring","mono":"<ul><li>quality\/diagnostic usefulness of lymphography<\/li><li>hypersensitivity reactions; minimum of 60 minutes after administration<\/li><\/ul>"},"11":{"id":"307240-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Subcutaneous Solution: 10 MG\/ML<br\/><\/li><li><b>Lymphazurin<\/b><br\/>Subcutaneous Solution: 10 MG\/ML<br\/><\/li><li><b>Novaplus Isosulfan Blue<\/b><br\/>Subcutaneous Solution: 10 MG\/ML<br\/><\/li><li><b>PremierPro Rx Isosulfan Blue<\/b><br\/>Subcutaneous Solution: 10 MG\/ML<br\/><\/li><\/ul>"},"13":{"id":"307240-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause discolored urine for up to 24 hours after administration.<\/li><li>This drug may cause skin discoloration on a temporary or long-term basis.<\/li><\/ul>"}}}